Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|
Total Revenue | -- | 9,305 | 7,043 | |
Cost of Revenue | -- | -- | -- | |
Gross Profit | -- | -- | -- | |
Operating Expenses | ||||
Research Development | -- | -- | -- | |
Selling General and Administrative | 2,845 | 5,743 | 3,949 | |
Non Recurring | -- | -- | -- | |
Others | 4,827 | (5,743) | (3,949) | |
Total Operating Expenses | 7,672 | -- | -- | |
Operating Income or Loss | (7,672) | -- | -- | |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | (2,317) | -- | -- | |
Earnings Before Interest And Taxes | 1,209 | -- | -- | |
Interest Expense | -- | 795 | 1,705 | |
Income Before Tax | 159 | 2,414 | (1,177) | |
Income Tax Expense | (21) | 487 | (474) | |
Minority Interest | -- | -- | -- | |
Net Income From Continuing Ops | 180 | 1,927 | (703) | |
Non-recurring Events | ||||
Discontinued Operations | 375 | -- | -- | |
Extraordinary Items | -- | -- | -- | |
Effect Of Accounting Changes | -- | -- | -- | |
Other Items | (375) | 0 | 0 | |
Net Income | 180 | 1,927 | (703) | |
Preferred Stock And Other Adjustments | -- | -- | -- | |
Net Income Applicable To Common Shares | 180 | 1,927 | (703) | |